These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 10353758

  • 1. Autologous high-killing cytotoxic T lymphocytes against human lung cancer are induced using interleukin (IL)-1beta, IL-2, IL-4, and IL-6: possible involvement of dendritic cells.
    Saijo Y, Hong X, Tanaka M, Tazawa R, Liu SQ, Saijo K, Ohno T, Koike K, Ohkuda K, Satoh K, Nukiwa T.
    Clin Cancer Res; 1999 May; 5(5):1203-9. PubMed ID: 10353758
    [Abstract] [Full Text] [Related]

  • 2. [Killing activity of cytotoxic T lymphocytes stimulated by dendritic cell vaccine loaded with autologous cervical cancer antigen].
    Zhou CJ, Ma W, Zhou JD, Zhao YX, Xie HQ.
    Ai Zheng; 2006 Feb; 25(2):143-7. PubMed ID: 16480575
    [Abstract] [Full Text] [Related]

  • 3. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.
    Imura K, Ueda Y, Hayashi T, Itoh T, Shimizu K, Tamai H, Yano Y, Naito K, Kohara J, Nakane K, Matsuura Y, Takeda A, Takeda T, Kawai K, Yamagishi H.
    Int J Oncol; 2006 Sep; 29(3):531-9. PubMed ID: 16865268
    [Abstract] [Full Text] [Related]

  • 4. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD, Hermonat PL, Ravaggi A, Bellone S, Pecorelli S, Cannon MJ, Parham GP.
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [Abstract] [Full Text] [Related]

  • 5. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
    Mogi S, Ebata T, Setoguchi Y, Fujime M, Heike Y, Kohsaka T, Yagita H, Okumura K, Azuma M.
    Clin Cancer Res; 1998 Mar; 4(3):713-20. PubMed ID: 9533541
    [Abstract] [Full Text] [Related]

  • 6. Generation of memory CD4+, CD8+, CD45RO+ and CD16- lymphocytes activated with IL-2, INF-gamma, and TNF-alpha with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture.
    Rangel R, Rocha L, Ramirez JL, Ibarra MJ, Solorza G, Monroy A, Ramirez MA, Herrera A, Weiss-Steider B.
    Eur Cytokine Netw; 1995 Mar; 6(3):195-202. PubMed ID: 8589277
    [Abstract] [Full Text] [Related]

  • 7. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
    Kimura H, Dobrenkov K, Iida T, Suzuki M, Ando S, Yamamoto N.
    Anticancer Res; 2005 Mar; 25(1A):85-94. PubMed ID: 15816523
    [Abstract] [Full Text] [Related]

  • 8. CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression.
    Radford KJ, Turtle CJ, Kassianos AJ, Hart DN.
    J Immunother; 2006 Mar; 29(6):596-605. PubMed ID: 17063122
    [Abstract] [Full Text] [Related]

  • 9. Generation of cytotoxic effector lymphocytes by MLTC using tumor cells genetically modified to secrete interleukin-2.
    Yamaguchi Y, Ohta K, Shimizu K, Minami K, Noma K, Hihara J, Toge T.
    Anticancer Res; 2001 Mar; 21(1B):669-77. PubMed ID: 11299824
    [Abstract] [Full Text] [Related]

  • 10. A dendritic cell-based tumour vaccine for lung cancer: full-length XAGE-1b protein-pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro.
    Zhou Q, Guo AL, Xu CR, An SJ, Wang Z, Yang SQ, Wu YL.
    Clin Exp Immunol; 2008 Sep; 153(3):392-400. PubMed ID: 18803763
    [Abstract] [Full Text] [Related]

  • 11. A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2.
    Correale P, Micheli L, Vecchio MT, Sabatino M, Petrioli R, Pozzessere D, Marsili S, Giorgi G, Lozzi L, Neri P, Francini G.
    Br J Cancer; 2001 Nov 30; 85(11):1722-30. PubMed ID: 11742494
    [Abstract] [Full Text] [Related]

  • 12. Cytokine combinations for induction of antigen-specific cytolytic T lymphocytes from peripheral blood lymphocytes.
    Tsujitani S, Nakashima M, Watanabe T, Kaibara N, Koprowski H, Steplewski Z.
    Anticancer Res; 1995 Nov 30; 15(3):655-60. PubMed ID: 7645938
    [Abstract] [Full Text] [Related]

  • 13. Effect of insulin on functional status of cord blood-derived dendritic cells and on dendritic cell-induced CTL cytotoxicity against pancreatic cancer cell lines.
    Liu QL, Wang YS, Wang JX.
    Hepatobiliary Pancreat Dis Int; 2009 Oct 30; 8(5):529-34. PubMed ID: 19822498
    [Abstract] [Full Text] [Related]

  • 14. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
    Koido S, Hara E, Homma S, Torii A, Toyama Y, Kawahara H, Watanabe M, Yanaga K, Fujise K, Tajiri H, Gong J, Toda G.
    Clin Cancer Res; 2005 Nov 01; 11(21):7891-900. PubMed ID: 16278414
    [Abstract] [Full Text] [Related]

  • 15. [Investigation on specific killing acute leukemia cell reaction of the cytotoxic T lymphocyte induced by dendritic cell pulsed with frozen-thawed antigen].
    He B, Qiu G, Xie X.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec 01; 21(6):974-8. PubMed ID: 15646345
    [Abstract] [Full Text] [Related]

  • 16. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
    de la Barrera S, Finiasz DM, Fink S, Valdez R, Bottasso O, Balina LM, Sasiain MC.
    Int J Lepr Other Mycobact Dis; 1997 Mar 01; 65(1):45-55. PubMed ID: 9207753
    [Abstract] [Full Text] [Related]

  • 17. HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating lymphocytes of patients with non-small cell lung cancer.
    Seki N, Hoshino T, Kikuchi M, Hayashi A, Itoh K.
    Cell Immunol; 1997 Feb 01; 175(2):101-10. PubMed ID: 9023415
    [Abstract] [Full Text] [Related]

  • 18. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
    Xu JJ, Yao K, Yu CJ, Chen X, Lu MP, Sun H, Li BZ, Ding CN, Zhou F.
    Auris Nasus Larynx; 2006 Dec 01; 33(4):441-6. PubMed ID: 16934422
    [Abstract] [Full Text] [Related]

  • 19. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H.
    Cancer Res; 2000 Sep 01; 60(17):4838-44. PubMed ID: 10987295
    [Abstract] [Full Text] [Related]

  • 20. The anti-human tumor effect and generation of human cytotoxic T cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the Interleukin-6 gene using adenovirus vector.
    Tanaka F, Abe M, Akiyoshi T, Nomura T, Sugimachi K, Kishimoto T, Suzuki T, Okada M.
    Cancer Res; 1997 Apr 01; 57(7):1335-43. PubMed ID: 9102222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.